Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hormona

Explore full profile

An app and personalized programs to help women understand and live in harmony with their hormones

London, United KingdomFounded 2019Health Tech & Medtech
Valuation $25–50M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Hormona and the history behind them.

About Hormona

Hormona.io is a pioneering startup that offers a comprehensive solution for women to understand and manage their hormonal health. The company operates in the health tech market, specifically focusing on women's health. Its primary offering is an app that provides personalized, evidence-based advice to help women understand their hormones better. The app allows users to track their symptoms, receive tailored tips, and gain valuable insights into their hormonal health.

In addition to the app, Hormona is also developing AI-powered at-home hormone tests that provide instant results in just 15 minutes. This allows women to track their hormone levels from the comfort of their home, eliminating the need for frequent doctor visits and lab tests.

Hormona's business model is likely based on a freemium model where basic features of the app are available for free, while advanced features and the hormone tests are available for a fee. This model allows the company to reach a wide audience while generating revenue from premium services.

The app also offers a range of additional features such as personalized recipes designed for each cycle phase, daily highlights, and access to exclusive learning modules about the endocrine system, menstrual cycle, and hormones. These features are designed to help women live in sync with their bodies and make informed decisions about their health.

In conclusion, Hormona.io is a unique startup that combines technology and medical science to empower women to take control of their hormonal health. It operates in a niche market with significant potential for growth, given the increasing focus on personalized healthcare.

Source: Dealroom company data

At a glance

Founded
2019
Headquarters
London, United Kingdom
Sector
Health Tech & Medtech

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

  • SFC Capital
  • Techstars
  • Nascent crypto
  • Supernode Global
  • Voima Ventures
  • DLF Venture
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
10 countries with
team presence
🇸🇪 Sweden33.3%
🇬🇧 United Kingdom28.6%
🇺🇸 United States4.8%
🇵🇱 Poland4.8%
🇽🇰 Kosovo4.8%
Top 5 of 10 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hormona on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hormona on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.